180 Life Sciences Corp

NASDAQ:ATNF   3:59:58 PM EDT
5.38
+0.08 (+1.61%)
Products, Regulatory

Celltrion Healthcare Says Co And 180 Life Sciences Enter Into Memorandum Of Understanding

Published: 09/20/2021 12:24 GMT
180 Life Sciences Corp (ATNF) - Celltrion Healthcare and 180 Life Sciences Enter Into Memorandum of Understanding for a Supply Agreement for Ongoing Supply of Drug for Anti-tnf Product Trials for Novel Indications.
180 Life Sciences Corp - Will Continue to Conduct Clinical Trials for Two Product Candidates and Has a Planned Clinical Trial for Its Next Candidate.
180 Life Sciences Corp - Celltrion Healthcare is Expected to Provide Drug Supply of Their Anti-tnf Biosimilar Products for Clinical Trials As Required.